A simple radioimmunoassay for the measurement of l7cx-hydroxyprogesterone in 0'1-0·25 ml serum is described. An antibody prepared against 17cx-hydroxyprogesterone 3(0carboxymethyl)-oxime-BSA as immunogen was used. A correlation of the 17ct:-hydroxyprogesterone concentration found in the serum of normal subjects and of patients with that obtained by a more
complex immunological purification method was good (r=0'924, P < 0,001). Accuracy, precision, and specificity were acceptable with the simple method. Normal values for infants, children, and adults have been established, and the individual concentrations of 17cx-hydroxyprogesterone in the serum of patients with congenital adrenal hyperplasia were well separated from normal values.
There is increasing interest in the use of methods that measure 17tX-hydroxyprogesterone (I7-0HP) concentrations in serum as an aid to the diagnosis and therapeutic management of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. A number of radioimmunoassay methods have been described (Abraham et al., 1971; Youssefnejadian et al., 1972; Franks, 1974; Hami et al., 1975; Janne et al., 1975; Wickings, 1975; Kaplan, 1977; Forest and Cathiard, 1978; Hughes and Winter, 1978; Parth et al., 1978) , but in the majority various degrees of purification of the serum extract are considered necessary. This detracts from the value of these methods when a result is required urgently.
The present study is concerned with the development of a simple radioimmunoassay that can be completed in a day. An antiserum with a high avidity for 17-0HP, prepared against 17-0HP-3 (O-carboxymethyl)-oxime-bovine serum albumin, was chosen, and evidence is given that, with this antiserum, satisfactory specificity can be obtained with a simple extraction procedure.
The method of Hami et al., (1975) , which employs an immunological purification technique, was used as a reference procedure.
The concentrations of 17-0HP found in the serum of normal infants, children, men and women, and patients with congenital adrenal hyperplasia, are reported.
Materials and methods
Tris HCl buffer, pH 8'0, 0·05 M in glass distilled water: Gelatin 0·1 % (British Drug Houses Ltd, Poole, UK) in Tris HCl buffer.
Diethylether (analytical grade, British Drug Houses, Poole, UK) redistilled before use.
17a-Hydroxyprogesterone (Steraloids Ltd, Croydon, UK): all other steroids used for cross reactivity studies were either purchased from the same source or were gifts from the Medical Research Council Steroids Reference Collection.
1,2 3H(N) 17-0HP, specific activity 40·4 Cit mmol (New England Nuclear, Dreieichenhain, West Germany). This was used without further purification.
Norit A charcoal (Sigma Chemicals, Poole, UK) and Dextran T70 (Pharmacia (GB) Ltd, London, UK). A suspension in buffer containing 0·24 g charcoal and 0·024 g dextran per 100 ml of buffer was prepared.
Scintillation fluid contained 5 g of PPO and 0·5 g dimethyl POPOP in 1 litre toluene.
The conjugate 17-0HP-3-oxime-BSA used for immunisation was prepared according to the method of Erlanger et al., (1957) . The product was found by optical density and radioactivity measurements to contain 15 molecules of 17-0HP associated with each molecule of bovine serum albumin. Two New Zealand White rabbits were immunised with a primary dose of 100 ug by the multisite intradermal technique (Vaitukaitis et al., 1971) . Booster doses (100~g) were given after five months and after a further three months. Antiserum, collected one month after the second boost, was used at a final dilution of 1/60000. The intrinsic association constant (K.), calculated by the procedure of Scat chard (1949), was 9'7 x 10 9 lImo!. APPARATUS Automatic dispensing pipettes (Boehringer Corporation, (London) Ltd) 10 to 500~l range.
Vortex mixer. Glass tubes for the assay 75 mrn x 10 mm. Refrigerated centrifuge (MSE 4L). Liquid scintillation spectrometer (Packard Tri Carb 3320) with a maximum efficiency of 55 % for 3H using disposable plastic minivials (MH Plastics Ltd, Romford, Essex, UK).
IMMUNOLOGICAL PURIFICATION PROCEDURE
The method of Hami et al. (1975) was used except that the antibody was prepared against 17-0HP-3(O-carboxymethyl)-oxime-BSA conjugate instead of against 17-0HP-7a-carboxyethylthioether-BSA conjugate. All other conditions were as originally described.
METHOD FOR 17-0HP ASSAY AFTER ETHER

EXTRACTION
Sample extraction
Thirty to forty serum samples were processed in each assay using a volume of 0·1-0·25 ml of serum, depending upon the anticipated 17-0HP concentration. Samples from patients with untreated adrenal hyperplasia were diluted 1:10 or I :50, and 0·05 ml was used. Double distilled water blanks, low and high control serum samples were also taken through the extraction procedure.
Diethylether (6 ml) was added to each tube and vortex mixed for I minute, followed by aspiration of the serum layer with a Pasteur pipette. The solvent layer was washed with 0·5 ml of redistilled water. The extraction tubes were then snap-frozen in a mixture of solid carbon dioxide and methanol, and the supernatant ether was decanted into glass tubes and dried under a stream of filtered air in a water bath at 37°C. The extract was reconstituted in I ml of Tris buffer, and duplicate 0·3 ml volumes were used for the radioimmunoassay. Davila, Rudd, Morris, Kandeel, Bodden, and London RADIOIMMUNOASSAY Duplicate aliquots of the 17-0HP standards containing 0,03, 0'076, 0'15, and 0·30 pmol in 0·1 ml ethanol were taken into assay tubes, and the ethanol was evaporated. Duplicate blank tubes containing the residue from 0·1 ml of dried ethanol were included as 'zero' tubes. The contents of each tube was reconstituted with 0·3 ml of buffer. To the samples, standards, and controls was added 0·2 ml of the antibody (l :20 000), and the contents of the tubes were mixed and allowed to stand at room temperature for 30 minutes. After the addition of 0·1 ml of [3H]-17-0HP in buffer (containing approximately 3000 cpm) the tubes were incubated overnight at 4°C. Tubes containing 0'1 ml of [3H]_ 17-0HP solution and 1·0 ml buffer were included in order to assess the total count.
Separation of the free from bound hormone was achieved by adding 0'5 ml of dextran-coated charcoal suspension. The tubes were mixed, allowed to stand in an ice water bath for 10 minutes, and then centrifuged for 10 minutes at 2500g. An aliquot (0'5 ml), of each supernatant was added to 2 ml volumes of toluene scintillant. Radioactive counting of the bound fraction was carried out after the addition of 0·1 ml of I M HCI to the scintillation vials, as described by Kandeel et al., (1976) . The percentage bound [3H]-17-0HP was calculated for the standards and samples. A standard curve was plotted, and the 17-0HP content of each sample was calculated from this.
EXPERIMENTAL METHODS
Choice of charcoal concentration
Charcoal concentrations (0'24-0·36%) were tested to determine the minimum concentration required to remove maximum quantities of free label in the absence of antibody. The nonspecific binding was minimal (1'0-1'7~;.;) throughout this concentration range with fresh reagents. Nonspecific binding rose to 5 % after storing the reagents for more than 48 hours. Fresh reagent at a concentration of 0·24 % was therefore selected.
Incubation time and precision of standard curves
The optimum preincubation time with unlabelled hormone that was required to achieve maximum sensitivity was investigated between 10 minutes and 2 hours. The binding of antibody in the zero tube did not change significantly between 30 minutes and 2 hours. Therefore a 3D-minute preincubation time was selected. A 3D-minute preincubation followed by an overnight incubation with label at 4°C gave an acceptable standard curve over the operating range. Figure 1 shows that the overnight incubation may be reduced to 2 hours without significant change in sensitivity. The per cent of label bound for standard ccurves incubated for 2 hours was within one standard deviation of the mean for curves incubated for 24 hours. The precision of 24 standard curves during a period of six months employing the 24-hour incubation step was investigated. The coefficient of variation for these curves ranged from 8'5 % (0,03 pmol) to 19-'% (0-30 pmol),
Accuracy
As an index of accuracy, unlabelled 17-0HP was added to steroid-free (charcoal-treated) serum in the range 0·15-0·60 pmol/tube (n=6). Recovery was linear over this concentration range, with mean (± 1SD) values of 89±7'2% (0'15 pmol), 92·4 ±7·8% (0'30 pmol), and 94·0±16·9% (0'60 pmol). The recovery of added 3H-17-0HP was 95·3 ±8 % (n = 1(0). In routine practice the addition of labelled marker was not considered necessary.
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Specificity
Progesterone, ll-deoxycortisol, and 17a-hydroxypregnenolone were the only steroids that showed significant cross-reactivity. The cross-reactivities using the proposed method and calculated by the method of Abraham (1975) were: l7et-hydroxypregnenolone 7·1 %, progesterone 4-5%, and 11deoxycortisol 5·5% (17-0HP 100%). Two concentrations of these steroids were added separately to 0·1 ml samples of steroid-free serum and assayed by the proposed method and the method of Rami et al. (1975) . Recoveries of 17-0HP and the crossreactants (calculated as 17-0RP and corrected for losses) are shown in Table 1 .
Comparison with immunological purification method
The method of Rami et al. (1975) was used as the reference method for comparison with the proposed technique.
Thirty-five samples were assayed by both procedures with 17-0HP concentrations in the range < 1'0-> 12 nrnol/l. The higher values (8-> 12 nmol/l) were obtained after the administration of ACTH (0'5 mg twice daily for three days) to Intra-assay and interassay variation Intra-assay coefficient of variation measured on 27 pairs of samples with a mean concentration of 5·3 nmol/l was 7·1 %, with a standard deviation of ±0·38 nmol/l, Control serum with a mean concentration of 6'09 nmol/l of 17-0HP was assayed over six months. The interassay standard deviation during this period was ±0'79 nrnol/l (n=18) with a coefficient of variation of 13 %. 
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Limits of detection
The limit of detection, defined as that quantity of steroid that could be distinguished from no hormone, was calculated according to the procedure of Midgley et al. (1969) . The value was 0·03 pmol/tube (n=24). patients with hirsutism. Figure 2 indicates that the correlation between the two methods (r=0'924, P < 0'001) was acceptable. However, two values obtained by the reference method were higher than expected when compared to the results obtained by the proposed procedure. The regression equation was of the form y (immunological method) = 0'9125x + 0'6. Hami et al. (1975) and the proposed extraction method.
Results
NORMAL VALUES OBTAINED BY THE SIMPLE EXTRACTION PROCEDURE
In/ants Capillary blood samples collected during the morning by heel prick were obtained from 31 infants as part of a neonatal survey for thyroid disease. None of the infants studied had biochemical or clinical evidence of thyroid or adrenal insufficiency. Ages ranged from 5 to 11 days; there were 14 girls and 17 boys with birth weights of between 2·32 and 4·24 kg. Infants of mothers with pre- Davila, Rudd, Morris, Kandeel, Bodden, and London eclampsia or receiving antidepressants were omitted from the study.
Children
Venous blood was obtained at either 1000 or 1400 from outpatients undergoing investigations for delayed growth. None had biochemical evidence of adrenal or pituitary growth hormone deficiency when investigated with a standard insulin provocation test. There were 16 children; 9 girls and 7 boys. Ages ranged from 4 to 15 years. The definitive diagnosis was constitutional short stature in all but two, one of which, a 4-year old girl, had premature thelarche, and the second delayed growth associated with coeliac disease. All patients were on Tanner pubertal stage I except one who rated stage II.
Adults
Venous blood samples were collected between 1400 and 1500 from 11 men (laboratory staff, age range 21-48 years) and 10 women (patients, age range 21-36 years). None had clinical or laboratory evidence of endocrine disease and all the women were menstruating normally.
Ten women were studied both in the follicular phase (days 4-8) and in the luteal phase (days 17-23) of the cycle.
Patients with congenital adrenal hyperplasia (CAH)
Eight untreated patients with CAH due to adrenal 21-hydroxylase deficiency were studied. Five were infants of 1 to 4 weeks of age, and three, children of 4-8 years. A definitive diagnosis was obtained for each based on clinical presentation (vomiting, salt loss), increased pregnanetriol in the urine, and/or an abnormal ll-oxygenation index. Venous blood was obtained at random times throughout the day for the 17-0HP measurements.
ANALYSIS OF DATA Table 2 shows mean, range, or standard deviation for each group studied. All patient groups were tested for normality by the Kolmogorov-Smirnov test (Wu et al., 1975) . A non-parametric test (Mann-Whitney 'U' Signed Rank) was used to compare t Mean value for follieu.lar phase .ignifieantly (p < 0,001) lower than luteal. t Mean value for neonates significantly (p < 0-01) higher than for children. patient group means if any results were not normally distributed.
Discussion
The measurement of serum 17-0HP concentrations as an alternative to urinary pregnanetriol excretion (Bongiovanni and Clayton, 1954; Morris, 1959) or the ll-oxygenation index (Hill, 1960; Edwards et al., 1964) has been reported for the diagnosis of patients with congenital adrenal hyperplasia due to Zl-hydroxylase deficiency (Strott et al., 1969; Pham-Huu-Trung et al., 1973) , and, with some rare exceptions , pregnanetriol in urine reflects this excessive production of 17-0HP. The detection of a diminished 21-hydroxylase activity in the non-salt losing form of the disease in children and adults can be revealed by ACTH stimulation and concurrent measurement of blood levels of 17-0HP or pregnanetriol in urine Barnes and Atherden, 1972; Givens et al., 1975; Newmark et al., 1977; Parth et al., 1978) . The monitoring of adequacy of treatment by the sequential measurement of 17-0HP in serum has been favoured (Loras et al., 1974; Hughes and Winter, 1978) . In contrast, Von Schnakenberg et al. (1974) and Grant et al. (1977) have questioned the value of 17-0HP as a therapeutic index of control. To establish definitive answers to the problem of whether 17-0HP levels in blood are the best index of adequate therapy requires methods of acceptable specificity, precision, and well-defined 17-0HP ranges for hospitalised patients of all ages. The present study goes some way to obtain these reference data.
The results reported by the simple extraction procedure compare well with values reported by other investigators who have employed secondary purification steps of varying complexity (Table 3 ). However, as was shown in the cross-reactivity and recovery studies, some interference by progesterone, 11-deoxycortisol, and 17a-OH-pregnenolone can be expected. Further, with the antiserum employed, the immunological purification technique did not entirely eliminate this interference.
The patients with clinical and biochemical evidence of adrenal 21-hydroxylase deficiency had, as expected, a very high and variable concentration of 17-0HP in their serum; this concentration was always well separated from the upper limits for the hospitalised controls or the ambulant normals.
The samples collected from the hospitalised patients were randomised with respect to time of day, age, and sex in order to obtain the maximum likely variation in 17-0HP concentrations that might be expected in normal clinical practice. Data collected during the early hours of sleep (2400-0300) have not been included. Bacon et al. (1977) have shown that a normal diurnal rhythm for 17-OHP does exist in patients with a hydroxylase deficiency but the concentration of 17-0HP in the blood of these patients is significantly higher than normal throughout the day. The results from the patients with CAH in the present study support this view because the samples studied were obtained at random times during the day.
It was of interest to note that the infants in the age range 5-11 days had a higher mean concentration of 17-0HP when compared to the mean 17-0HP for children (Table 2 ). The mean concentration found for the infants compares very favourably with the mean for infants of 7-11 days reported by Forest and Cathiard (1978) .
In contrast to other reports (Abraham et al., 1971; Wickings, 1975) , the mean concentration of 17-0HP in the serum of women in the luteal phase of the menstrual cycle was significantly higher than that during the follicular phase. Youssefnejadian et al. (1972) , as in the present study, were able to distinguish between a lower mean level of 17-0HP (days 4-8 of the cycle) and the mean level found for days 18-28 of the cycle in pools of serum from healthy women. Further studies with the simple extraction method are required to assess whether the technique will distinguish the midcycle peak of 17-0HP as demonstrated by Hami et al. (1975) and Aedo et al. (1976) . 
